Drug companies are still focused on raising prices, but some in the industry realize things need to change

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

Health care executives gave no indication to bankers and investors at this year's J.P. Morgan Healthcare Conference that their pricing practices would change any time soon.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.

Liquid or syrup supplements.

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 729. in SE

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

House Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices. Why are they being investigated when Trump claimed that drug prices are at an all time low? I just hope the Democrats don't just waste taxpayer dollars with meaningless politically motivated crap like everyone expects them to. This seems a needed topic, but stay away from political theater Democrats. Just watch the SJC in 2018 if you want to see your embarrassment. Nice to see them investigating actual wrong doing and not just investigating HRC again.
Källa: CNBC - 🏆 12. / 72 Läs mer »

Analysis | The Health 202: Health-care industry preps offense against Medicare-for-AllThe Health 202: Health-care industry preps offense against Medicare-for-All Can't cure patients, that hurts long term profits! It's Tuesday.
Källa: washingtonpost - 🏆 95. / 72 Läs mer »